U.S. Wireless Telecom Stock News

Weibo Corporation has reported its fourth-quarter and full-year 2025 results, with quarterly revenue rising to US$473.26 million but moving from net income to a net loss, while full-year revenue inched up to US$1.76 billion and net income increased to US$449.02 million. Alongside these results, the company’s board approved an annual cash dividend of US$0.61 per ordinary share or ADS for 2025, signaling a continued return of capital to shareholders despite the weaker fourth-quarter...

Vistra (NYSE:VST) has secured investment grade ratings from both Fitch and S&P. The dual ratings reflect stronger credit metrics and a balance sheet that supports a higher-quality credit profile. This credit upgrade may influence Vistra’s access to capital and its future financing terms. For shareholders watching NYSE:VST, the move to dual investment grade comes after a period of strong multi year share price gains alongside more recent pullbacks. The stock is trading at $150.33, with a 1...

On 21 March 2026, CNA Financial Corporation was removed from the FTSE All-World Index (USD), meaning it no longer features in this broad global equity benchmark. This index removal can matter for investors because it may alter how index-tracking funds and benchmark-aware portfolios treat CNA Financial within diversified allocations. Next, we’ll examine how CNA Financial’s exclusion from the FTSE All-World Index could influence its previously positive, efficiency-focused investment...

McCormick (MKC) opened fiscal 2026 with Q1 revenue of US$1,873.9 million and basic EPS of US$3.78, set against trailing twelve month revenue of US$7.1 billion and EPS of US$6.12, where earnings over the last year were reported as up 109.4%. Over recent quarters the company has seen revenue move from US$1,605.5 million in Q1 2025 to US$1,850.4 million in Q4 2025 and then to US$1,873.9 million in Q1 2026. Quarterly EPS tracked from US$0.60 to roughly the mid US$0.80 range before the latest step...

The United States market remained flat over the last week but has seen a 16% increase over the past year, with earnings anticipated to grow by 15% annually in the coming years. In this context, identifying high growth tech stocks involves looking for companies that not only demonstrate strong innovation and scalability but also align well with these promising market conditions.

In the last week, the United States market has stayed flat, yet it is up 16% over the past year with earnings forecast to grow by 15% annually. In this context, identifying stocks that might be undervalued based on current market estimates can offer investors opportunities to capitalize on potential growth while aligning with broader market trends.

The United States market has remained flat over the last week, yet it has seen a notable 16% rise over the past year, with earnings forecast to grow by 15% annually. In this context, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company's operations and strategy.

Yum! Brands appointed former Marriott CFO Kathleen (Leeny) K. Oberg to its Board of Directors, adding extensive global finance and hospitality experience. The company plans to close 250 underperforming Pizza Hut locations under its Hut Forward plan. Yum! Brands is transferring 20 Taco Bell outlets in Australia to a new operator, signaling a reset of parts of its international footprint. Yum! Brands (NYSE:YUM) is trading at $155.48, with a value score of 2 and a mixed return profile that...

Investors may be wondering if Celcuity at around US$114 a share is still offering value, or if most of the upside has already been priced in. The stock has delivered a 3.6% return over the last 7 days, 5.4% over 30 days and 13.5% year to date, while the 1 year and 3 year returns are very large and the 5 year return is around 7x. Recent market attention has focused on Celcuity's position in the biotechnology space and the potential implications of its clinical and pipeline updates for long...

In March 2026, Electronic Arts Inc was removed from the NASDAQ Internet Index, even as the company reported strong year-over-year EPS and revenue growth. Analysts have since raised their earnings estimates for EA, suggesting the index removal coincided with improving confidence in the company’s underlying profitability profile. With analyst earnings estimates moving higher, we’ll now examine how this renewed business momentum reshapes Electronic Arts’ broader investment narrative. The...

Why Ternium (NYSE:TX) Is On Investors’ Radar Today Ternium (NYSE:TX) has drawn fresh investor attention after recent share price moves, with a 4.3% gain in the latest session and mixed returns over the past month and past 3 months. See our latest analysis for Ternium. With the share price now at US$40.15, Ternium’s recent 4.3% 1 day share price return comes after a 3.2% 7 day gain but follows a 7.6% 30 day share price decline, while the 1 year total shareholder return of 42.1% suggests...

Core & Main (NYSE:CNM) has appointed former American Water Works CEO M. Susan Hardwick to its board, effective April 1. The company has restructured key governance roles, including a new board chair and a new audit committee chair. The longstanding executive chair has retired as part of the succession changes. Core & Main, trading at $49.4, is adjusting its leadership structure after a 3-year return of 121.8% and a 1-year return of 0.0%. The share price has seen a 2.3% decline over the past...

Ocugen (NasdaqCM:OCGN) completed enrollment and dosing early in its pivotal Phase 2/3 GARDian3 trial for OCU410ST. The trial evaluates a one time gene therapy candidate for Stargardt disease, a severe inherited retinal disorder with no approved treatments. This is Ocugen's second late stage clinical program and aligns with its stated goal to submit multiple BLAs by 2028. For readers tracking gene therapy names, Ocugen sits at the intersection of rare ophthalmology and inherited retinal...

Generation Investment Management has already exited its position in Jones Lang LaSalle (JLL), citing rising competition and a belief that the company no longer stands out within commercial real estate services, while JLL’s own recent report underscores a global shortage of premium, post-2020 office space. This combination of an investor stepping back amid competitive pressures and JLL highlighting scarcity in top-tier real estate stock raises important questions about how the company’s...

Wondering if Meritage Homes at around US$61.84 is a bargain or fairly priced? This article focuses on what the current share price might be telling you about value. The stock has returned 1.5% over the last 7 days, while the 30 day return sits at an 18.0% decline and the one year return is a 10.7% decline, despite 3 year and 5 year returns of 12.0% and 39.0% respectively. Recent attention on Meritage Homes has centered on its share price performance and how housing related names are being...

Marsh & McLennan Companies (NYSE:MRSH) has announced a leadership transition at its consulting and risk businesses. Ted Moynihan has been named President and CEO of Marsh Management Consulting and Oliver Wyman. Nick Studer has been appointed President and CEO of Marsh Risk. For investors tracking NYSE:MRSH, these moves come with the shares at $173.45 and a mixed return profile, including a 7.9% gain over 3 years and 49.6% over 5 years, alongside a 27.7% decline over the past year. The...

If you are wondering whether Truist Financial's current share price reflects its underlying worth, the recent mix of returns provides plenty to think about. The stock last closed at US$45.97, with a 1.4% gain over 7 days, a 6.8% decline over 30 days, a 7.6% decline year to date, a 17.5% return over 1 year, a very large 69.3% return over 3 years, and a 1.6% decline over 5 years. Recent headlines around Truist Financial have focused on the broader banking sector, regulatory scrutiny, and...

On March 26, 2026, Ingevity Corporation entered into a Second Amended and Restated Credit Agreement that extended the maturity of its revolving credit facility by five years, reduced total commitments from US$1 billion to US$750 million, and repaid US$512.1 million of outstanding revolving loans. This move reshapes Ingevity’s financial toolkit, signaling an emphasis on disciplined liquidity management, lower standby borrowing capacity, and a refreshed banking agreement with updated covenant...

Alvotech has published its 2025 Annual Report and filed its Form 20-F, detailing progress in its biosimilar portfolio, including five approved products and a pipeline of nine additional candidates supported by global commercial partnerships. The company also reaffirmed its 2026 revenue guidance of US$650 million to US$700 million, highlighting a focus on cash flow and margin expansion through sales growth and operational efficiencies. With reaffirmed 2026 revenue guidance and expanded...

Vera Therapeutics has appointed Jane Wright-Mitchell as its new Chief Legal Officer. Wright-Mitchell brings extensive legal, compliance, and intellectual property experience in life sciences and pharmaceuticals. The appointment adds senior leadership depth as Vera Therapeutics continues to develop its pipeline. The new Chief Legal Officer steps in at a time when Vera Therapeutics, listed as NasdaqGM:VERA, is trading at $40.23. The share price reflects a mixed return profile, with a 1.2%...

In its latest reported quarter, Federated Hermes delivered revenue growth of 13.7% year on year, beating analyst expectations and ending the period with record assets, largely driven by higher money market balances. This performance underscored how strong demand for the firm’s liquidity products can support its overall business even when the wider custody bank sector is under pressure. We’ll now examine how this strong revenue beat and record money market assets may influence Federated...

RXO (RXO) shares are in focus after the company expanded its RXO Extra marketplace, rolling out a premium load booking experience with white glove onboarding, expanded digital load visibility and concierge support for participating carriers. See our latest analysis for RXO. The marketplace upgrade arrives as RXO’s share price sits at $14.62, with a 1-day share price return of 6.25% and 90-day share price return of 15.66%. However, a 1-year total shareholder return decline of 22.73% suggests...

If you are wondering whether Sun Communities at around US$125.96 is offering fair value right now, you are not alone, many investors are asking the same question. The stock’s recent returns have been mixed, with a 2.2% decline over the last week, a 7.7% decline over the last month, but a 3.1% gain year to date and 4.8% over the past year. These moves come as Sun Communities continues to attract attention as a Residential REIT, with investors weighing its track record over the last 3 and 5...

Amer Sports (NYSE:AS) is drawing fresh investor attention after outlining plans to lift IT capital expenditures to US$400 million in 2026, with a focus on cloud infrastructure, SAP S/4HANA, and embedded AI tools. See our latest analysis for Amer Sports. The plan to lift IT spending comes as Amer Sports’ share price sits at US$32.92, with a 1-day share price return of 6.16% contrasting with a 30-day share price return decline of 13.32%, while the 1-year total shareholder return of 22.79%...